Credit: REUTERS/JACOB GRONHOLT-PEDERSENCOPENHAGEN, Aug 5 (Reuters) - Denmark's Novo Nordisk NOVOb.CO posted a better-than-expected quarterly operating profit on Thursday and slightly lifted its full-year earnings outlook, the company said.
The world's top maker of diabetes drugs posted a second-quarter operating profit of 13.8 billion Danish crowns ($2.20 billion), compared to an average 13.31 billion expected by analysts in a Refinitiv poll. L8N2F61E2
The company now expects annual operating profit growth in the range of 2-5%, up from an earlier estimate of 1-5% growth.
($1 = 6.2705 Danish crowns)
(Reporting by Nikolaj Skydsgaard Editing by Shri Navaratnam)
((Nikolaj.Skydsgaard@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
